Use of recombinant factor VIIa (NovoSeven®) in patients with Glanzmann thrombasthenia
- 1 October 2001
- journal article
- review article
- Published by Elsevier in Seminars in Hematology
- Vol. 38, 21-25
- https://doi.org/10.1016/s0037-1963(01)90143-x
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Bone marrow transplantation in severe Glanzmann's thrombasthenia with antiplatelet alloimmunizationBone Marrow Transplantation, 2000
- Use of Recombinant Factor VIIa in 3 Patients with Inherited Type I Glanzmann’s Thrombasthenia Undergoing Invasive ProceduresThrombosis and Haemostasis, 2000
- The use of recombinant factor Vila in a patient with severe Glanzmann??s thrombasthenia to facilitate insertion of a Port-a-Cath??Blood Coagulation & Fibrinolysis, 1999
- Successful Epistaxis Control in a Patient with Glanzmann Thrombasthenia by Increased Bolus Injection Dose of Recombinant Factor VIIaThrombosis and Haemostasis, 1999
- Hematologically Important Mutations: Glanzmann ThrombastheniaBlood Cells, Molecules, and Diseases, 1997
- Dental Considerations for a Glanzmann's Thrombasthenia Patient: Case ReportThe Journal of Periodontology, 1996
- Pharmacologic agents in the management of bleeding disordersTransfusion, 1990
- Glanzmann's thrombasthenia: the spectrum of clinical diseaseBlood, 1990
- Use of DDAVP in inherited and acquired platelet dysfunctionAmerican Journal of Hematology, 1990
- Congenital bleeding disorders with long bleeding time and normal platelet countThe American Journal of Medicine, 1966